The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass

Clinical Endocrinology

Volumn 77, Issue 6, 2012, Pages 816-822

  Anastasilakis, Athanasios D ^a   Polyzos, Stergios A ^b   Delaroudis, Sideris ^a   Bisbinas, Ilias ^a   Sakellariou, Grigorios T ^a   Gkiomisi, Athina ^a   Papadopoulou, Evridiki ^c   Gerou, Spyridon ^d   Makras, Polyzois ^e  

^a 424 General Army Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c IKA Votsi ^*  (Greece)

^d Laboratories Analysis   (Greece)

^e IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BODY MASS; BODY TEMPERATURE; BONE MASS; CELL SUBPOPULATION; CLINICAL ASSESSMENT TOOL; FEMALE; HOMOEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; POSTMENOPAUSE; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VISUAL ANALOG SCALE;

ACUTE-PHASE REACTION; ADIPOKINES; AGE FACTORS; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CYTOKINES; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; INSULIN RESISTANCE; LYMPHOCYTE COUNT; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RISK FACTORS;

EID: 84869078162     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04459.x     Document Type: Article

References (34)

1. Reid, I.R., Gamble, G.D., Mesenbrink, P., et al,. (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. Journal of Clinical Endocrinology and Metabolism, 95, 4380-4387.
2. Thiébaud, D., Sauty, A., Burckhardt, P., et al,. (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcified Tissue International, 61, 386-392. (Pubitemid 27507904)
3. Schweitzer, D.H., Oostendorp-van de Ruit, M., Van der Pluijm, G., et al,. (1995) Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. Journal of Bone and Mineral Research, 10, 956-962.
4. Dicuonzo, G., Vincenzi, B., Santini, D., et al,. (2003) Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. Journal of Interferon and Cytokine Research, 23, 649-654. (Pubitemid 37452905)
5. van Beek, E., Pieterman, E., Cohen, L., et al,. (1999) Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochemical and Biophysical Research Communications, 264, 108-111. (Pubitemid 29500472)
6. Roelofs, A.J., Jauhiainen, M., Mönkkönen, H., et al,. (2009) Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. British Journal of Haematology, 144, 245-250.
7. Scheller, E.L., Hankenson, K.D., Reuben, J.S., et al,. (2011) Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production. Journal of Cellular Biochemistry, 112, 3364-3372.
8. Srivastava, T., Dai, H., Haney, C.J., et al,. (2011) Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate. Journal of Bone and Mineral Research, 26, 437-438.
9. Polyzos, S.A., Kountouras, J., &, Zavos, C., (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Current Molecular Medicine, 72, 299-314.
10. Pittenger, M.F., Mackay, A.M., Beck, S.C., et al,. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147. (Pubitemid 29282067)
11. Karsenty, G., (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metabolism, 4, 341-348. (Pubitemid 44645074)
12. Lee, N.K., Sowa, H., Hinoi, E., et al,. (2007) Endocrine regulation of energy metabolism by the skeleton. Cell, 130, 456-469. (Pubitemid 47208519)
13. Samal, B., Sun, Y., Stearns, G., et al,. (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology, 14, 1431-1437.
14. Chen, M.P., Chung, F.M., Chang, D.M., et al,. (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 91, 295-299.
15. Koch, A., Gressner, O.A., Sanson, E., et al,. (2009) Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Critical Care, 13, R95.
16. Moses, A.G., Dowidar, N., Holloway, B., et al,. (2001) Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients. British Journal of Surgery, 88, 588-593. (Pubitemid 32291243)
17. Bullõ, M., García-Lorda, P., Megias, I., et al,. (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research, 11, 525-531. (Pubitemid 41202413)
18. Park, M.C., Chung, S.J., Park, Y.B., et al,. (2009) Pro-inflammatory effect of leptin on peripheral blood mononuclear cells of patients with ankylosing spondylitis. Joint Bone Spine, 76, 170-175.
19. Anastasilakis, A.D., Polyzos, S.A., Makras, P., et al,. (2012) Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass. Bone, 50, 1130-1134.
20. Srivastava, T., Haney, C.J., &, Alon, U.S., (2009) Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion. Journal of Bone and Mineral Research, 24, 334-337.
21. Makras, P., Anastasilakis, A.D., Polyzos, S.A., et al,. (2011) No effect of rosuvastatin in the zoledronate-induced acute phase response. Calcified Tissue International, 88, 402-408.
22. Fiore, F., Castella, B., Nuschak, B., et al,. (2007) Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid. Blood, 110, 921-927. (Pubitemid 47267430)
23. Mariani, S., Muraro, M., Pantaleoni, F., et al,. (2005) Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia, 19, 664-670. (Pubitemid 40521173)
24. Li, W., Kubo, S., Okuda, A., et al,. (2010) Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2. Journal of Immunotherapy, 33, 287-296.
25. Sauty, A., Pecherstorfer, M., Zimmer-Roth, I., et al,. (1996) Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone, 18, 133-139.
26. Fukuhara, A., Matsuda, M., Nishizawa, M., et al,. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 307, 426-430. (Pubitemid 40139988)
27. Moschen, A.R., Kaser, A., Enrich, B., et al,. (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. Journal of Immunology, 178, 1748-1758. (Pubitemid 46154646)
28. Moschen, A.R., Gerner, R.R., &, Tilg, H., (2010) Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Current Pharmaceutical Design, 16, 1913-1920.
29. Hector, J., Schwarzloh, B., Goehring, J., et al,. (2007) TNF-alpha alters visfatin and adiponectin levels in human fat. Hormone and Metabolic Research, 39, 250-255. (Pubitemid 46715881)
30. Kralisch, S., Klein, J., Lossner, U., et al,. (2005) Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism, 289, 586-590.
31. Kukla, M., Mazur, W., Bułdak, R.J., et al,. (2011) Potential Role of Leptin, Adiponectin and Three Novel Adipokines-Visfatin, Chemerin and Vaspin-in Chronic Hepatitis. Molecular Medicine, 17, 1397-1410.
32. Oki, K., Yamane, K., Kamei, N., et al,. (2007) Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clinical Endocrinology (Oxford), 67, 796-800. (Pubitemid 47628470)
33. Kaibara, A., Moshyedi, A., Auffenberg, T., et al,. (1998) Leptin produces anorexia and weight loss without inducing an acute phase response or protein wasting. American Journal of Physiology, 274, R1518-R1525. (Pubitemid 28304266)
34. Pickup, J.C., Chusney, G.D., &, Mattock, M.B., (2000) The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction. Clinical Endocrinology (Oxford), 52, 107-112. (Pubitemid 30108292)